Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Upfront Immunotherapy + Chemotherapy for NSCLC

Upfront Immunotherapy for NSCLC

The Ever-Evolving Treatment Paradigm for NSCLC

The FDA’s Oncologic Drugs Advisory Committee voted 17-0 to recommend approval for ABP-215, a biosimilar for bevacizumab (Avastin) to treat a range of solid tumors.

ODAC Unanimously Supports Bevacizumab Biosimilar ABP-215

HER2 Status in Colorectal Cancer

Evidence in BRAF-Mutant CRC Tumors

CRC: Emerging Immunotherapy Strategies in MSS Tumors

Pembrolizumab in MSI-H CRC Tumors

Role of Trifluridine/Tipiracil in CRC

Patient Selection for Regorafenib in CRC

Sequencing Considerations in MSS CRC Tumors

Exploring Second-Line Therapeutic Options in mCRC

Global Perspectives and Initial Decisions in mCRC

IDEA Trial: 3 vs 6 Months of Adjuvant Therapy in CRC

 Exploring Global Variations in Molecular Profiling

Maintenance and Second-Line Decisions in mCRC

Frontline Decisions in RAS Wild-Type Left-Sided mCRC

Nuances in Antibody Selection: Left Vs Right-Sided mCRC

Prognostic/Predictive Value of Tumor-Sidedness in CRC

Colorectal Cancer Prevention and Screening: An Update

 Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.